Renal Cancers Completed Phase 2 Trials for Cyclophosphamide (DB00531)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002475Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerTreatment
NCT00002466Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone CancerTreatment
NCT00004135Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney CancerTreatment
NCT00027573Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney CancerTreatment
NCT00262886Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney CancerTreatment
NCT00787761Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerTreatment